Other languages Yield10 Bioscience

Equities

YTEN

US98585K8541

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-03 EDT			5-day change	1st Jan Change
5.6 ^USD	+1.80%		+5.20%	-2.49%

04-01	Transcript : Yield10 Bioscience, Inc., Q4 2023 Earnings Call, Apr 01, 2024
04-01	Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	04-01
Yield10 Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01
Yield10 Bioscience, Inc. Announces the Plant Biosafety Office of the Canadian Food Inspection Agency Clear Genome-edited E3902 Camelina for Planting in Canada	03-26
Top Midday Gainers	03-21
Yield10 Bioscience, Inc. Grants Global License to VISION Bioenergy Oilseeds, LLC for Herbicide Tolerant Camelina Cultivated for Production of Biofuel Feedstock	02-14
Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected	02-08
US Futures Marginally Lower Ahead of Jobless Claims, Wholesale Trade Data	02-08
Yield10 Bioscience, Inc. Provides an Update on Its Omega-3 Camelina Program	02-07
Yield10 Bioscience, Inc. Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil	01-08
Yield10 Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14
Yield10 Bioscience, Inc. Contemplates Bankruptcy.	11-14
Yield10 Bioscience, Inc. and Biomar Group Aim to Grow Fish Oil on Land	23-10-31
Yield10 Bioscience, Inc. Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Production Technology from Rothamsted Research	23-10-19
Sector Update: Health Care Stocks Softer Late Afternoon	23-10-18
Sector Update: Health Care	23-10-18
Yield10 Bioscience Acquires License to Commercialize Advanced Omega-3 Technology	23-10-18
Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research	23-10-18
Yield10 Bioscience, Inc. Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina	23-10-11
Yield10 Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Top Midday Decliners	23-08-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Yield10 Bioscience

Equities

YTEN

US98585K8541

Other languages

Filters